Association of body mass index and the depletion of nigrostriatal dopamine in Parkinson's disease

Jae Jung Lee; Jungsu S. Oh; Jee H. Ham; Dong H. Lee; Injoo Lee; Young H. Sohn; Jae S. Kim; Phil Hyu Lee

doi:10.1016/j.neurobiolaging.2015.11.009

Association of body mass index and the depletion of nigrostriatal dopamine in Parkinson's disease

Jae Jung Lee, Jungsu S. Oh, Jee H. Ham, Dong H. Lee, Injoo Lee, Young H. Sohn, Jae S. Kim, Phil Hyu Lee

Department of Neurology

Research output: Contribution to journal › Article › peer-review

26 Citations (Scopus)

Abstract

Several antecedent studies had reported close relationship between low body weight and Parkinson's disease (PD). However, there have been few investigations about the role of body weight to nigrostriatal dopaminergic neurodegeneration. This study enrolled 398 de novo patients with PD whom underwent [¹⁸F] N-(3-Fluoropropyl)-2β-carbon ethoxy-3β-(4-iodophenyl) nortropane positron emission tomography scan and body mass index (BMI) measurement. The relationships between BMI and dopamine transporter (DAT) activity were analyzed using linear regression analysis. A multivariate analysis adjusted for age, gender, disease duration, smoking status, coffee and tea consumption, and residence area revealed that BMI remained independently and significantly associated with DAT activity in all striatal subregions. Moreover, multiple logistic regression analyses showed that BMI was a significant predictor for the lowest quartile of DAT activity in the anterior putamen, ventral striatum, caudate nucleus, and total striatum. The present findings suggest that a low BMI might be closely associated with low density of nigrostriatal dopaminergic neurons in PD, which could support the evidence for the role of low body weight to PD-related pathologies.

Original language	English
Pages (from-to)	197-204
Number of pages	8
Journal	Neurobiology of Aging
Volume	38
DOIs	https://doi.org/10.1016/j.neurobiolaging.2015.11.009
Publication status	Published - 2016

Bibliographical note

Funding Information:
This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare , Republic of Korea (grant number: HI14C0093 ). Lee Jae Jung designed and conducted the study, analyzed clinical data, interpreted data, and drafted the article. Oh Jungsu S. and Lee Injoo analyzed imaging data. Ham Jee H. and Lee Dong H. conducted the study and collected clinical data. Sohn Young H. and Kim Jae S. conducted the study and analyzed imaging data. Lee Phil Hyu designed and conducted the study, interpreted data, drafted the article, and supervised the study.

Publisher Copyright:
© 2016 Elsevier Inc.

All Science Journal Classification (ASJC) codes

Neuroscience(all)
Ageing
Developmental Biology
Clinical Neurology
Geriatrics and Gerontology

Access to Document

10.1016/j.neurobiolaging.2015.11.009

Cite this

@article{d68d847a7655437e8048add113175273,

title = "Association of body mass index and the depletion of nigrostriatal dopamine in Parkinson's disease",

abstract = "Several antecedent studies had reported close relationship between low body weight and Parkinson's disease (PD). However, there have been few investigations about the role of body weight to nigrostriatal dopaminergic neurodegeneration. This study enrolled 398 de novo patients with PD whom underwent [18F] N-(3-Fluoropropyl)-2β-carbon ethoxy-3β-(4-iodophenyl) nortropane positron emission tomography scan and body mass index (BMI) measurement. The relationships between BMI and dopamine transporter (DAT) activity were analyzed using linear regression analysis. A multivariate analysis adjusted for age, gender, disease duration, smoking status, coffee and tea consumption, and residence area revealed that BMI remained independently and significantly associated with DAT activity in all striatal subregions. Moreover, multiple logistic regression analyses showed that BMI was a significant predictor for the lowest quartile of DAT activity in the anterior putamen, ventral striatum, caudate nucleus, and total striatum. The present findings suggest that a low BMI might be closely associated with low density of nigrostriatal dopaminergic neurons in PD, which could support the evidence for the role of low body weight to PD-related pathologies.",

author = "Lee, {Jae Jung} and Oh, {Jungsu S.} and Ham, {Jee H.} and Lee, {Dong H.} and Injoo Lee and Sohn, {Young H.} and Kim, {Jae S.} and Lee, {Phil Hyu}",

note = "Funding Information: This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare , Republic of Korea (grant number: HI14C0093 ). Lee Jae Jung designed and conducted the study, analyzed clinical data, interpreted data, and drafted the article. Oh Jungsu S. and Lee Injoo analyzed imaging data. Ham Jee H. and Lee Dong H. conducted the study and collected clinical data. Sohn Young H. and Kim Jae S. conducted the study and analyzed imaging data. Lee Phil Hyu designed and conducted the study, interpreted data, drafted the article, and supervised the study. Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2016",

doi = "10.1016/j.neurobiolaging.2015.11.009",

language = "English",

volume = "38",

pages = "197--204",

journal = "Neurobiology of Aging",

issn = "0197-4580",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Association of body mass index and the depletion of nigrostriatal dopamine in Parkinson's disease

AU - Lee, Jae Jung

AU - Oh, Jungsu S.

AU - Ham, Jee H.

AU - Lee, Dong H.

AU - Lee, Injoo

AU - Sohn, Young H.

AU - Kim, Jae S.

AU - Lee, Phil Hyu

N1 - Funding Information: This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare , Republic of Korea (grant number: HI14C0093 ). Lee Jae Jung designed and conducted the study, analyzed clinical data, interpreted data, and drafted the article. Oh Jungsu S. and Lee Injoo analyzed imaging data. Ham Jee H. and Lee Dong H. conducted the study and collected clinical data. Sohn Young H. and Kim Jae S. conducted the study and analyzed imaging data. Lee Phil Hyu designed and conducted the study, interpreted data, drafted the article, and supervised the study. Publisher Copyright: © 2016 Elsevier Inc.

PY - 2016

Y1 - 2016

N2 - Several antecedent studies had reported close relationship between low body weight and Parkinson's disease (PD). However, there have been few investigations about the role of body weight to nigrostriatal dopaminergic neurodegeneration. This study enrolled 398 de novo patients with PD whom underwent [18F] N-(3-Fluoropropyl)-2β-carbon ethoxy-3β-(4-iodophenyl) nortropane positron emission tomography scan and body mass index (BMI) measurement. The relationships between BMI and dopamine transporter (DAT) activity were analyzed using linear regression analysis. A multivariate analysis adjusted for age, gender, disease duration, smoking status, coffee and tea consumption, and residence area revealed that BMI remained independently and significantly associated with DAT activity in all striatal subregions. Moreover, multiple logistic regression analyses showed that BMI was a significant predictor for the lowest quartile of DAT activity in the anterior putamen, ventral striatum, caudate nucleus, and total striatum. The present findings suggest that a low BMI might be closely associated with low density of nigrostriatal dopaminergic neurons in PD, which could support the evidence for the role of low body weight to PD-related pathologies.

AB - Several antecedent studies had reported close relationship between low body weight and Parkinson's disease (PD). However, there have been few investigations about the role of body weight to nigrostriatal dopaminergic neurodegeneration. This study enrolled 398 de novo patients with PD whom underwent [18F] N-(3-Fluoropropyl)-2β-carbon ethoxy-3β-(4-iodophenyl) nortropane positron emission tomography scan and body mass index (BMI) measurement. The relationships between BMI and dopamine transporter (DAT) activity were analyzed using linear regression analysis. A multivariate analysis adjusted for age, gender, disease duration, smoking status, coffee and tea consumption, and residence area revealed that BMI remained independently and significantly associated with DAT activity in all striatal subregions. Moreover, multiple logistic regression analyses showed that BMI was a significant predictor for the lowest quartile of DAT activity in the anterior putamen, ventral striatum, caudate nucleus, and total striatum. The present findings suggest that a low BMI might be closely associated with low density of nigrostriatal dopaminergic neurons in PD, which could support the evidence for the role of low body weight to PD-related pathologies.

UR - http://www.scopus.com/inward/record.url?scp=84962256676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962256676&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2015.11.009

DO - 10.1016/j.neurobiolaging.2015.11.009

M3 - Article

C2 - 26827658

AN - SCOPUS:84962256676

VL - 38

SP - 197

EP - 204

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

ER -

Association of body mass index and the depletion of nigrostriatal dopamine in Parkinson's disease

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this